- Home
- Publications
- Publication Search
- Publication Details
Title
Osteoprotegerin in breast cancer: beyond bone remodeling
Authors
Keywords
Osteoprotegerin, Bone, TNF-related apoptosis inducing ligand (TRAIL), Apoptosis, Angiogenesis, Metastasis
Journal
Molecular Cancer
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-06-11
DOI
10.1186/s12943-015-0390-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer
- (2014) Nicole Sänger et al. Molecular Oncology
- Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis
- (2014) Michael Weichhaus et al. Cancer Medicine
- Mechanistic study of the proangiogenic effect of osteoprotegerin
- (2013) Zahia Benslimane-Ahmim et al. ANGIOGENESIS
- Genetic polymorphism of the OPG gene associated with breast cancer
- (2013) Jasmin Teresa Ney et al. BMC CANCER
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
- (2012) David L. Lacey et al. NATURE REVIEWS DRUG DISCOVERY
- Dual Function of ERR in Breast Cancer and Bone Metastasis Formation: Implication of VEGF and Osteoprotegerin
- (2011) A. Fradet et al. CANCER RESEARCH
- Molecular Pathways: Osteoclast-Dependent and Osteoclast-Independent Roles of the RANKL/RANK/OPG Pathway in Tumorigenesis and Metastasis
- (2011) W. C. Dougall CLINICAL CANCER RESEARCH
- Arming a replicating adenovirus with osteoprotegerin reduces the tumor burden in a murine model of osteolytic bone metastases of breast cancer
- (2010) J J Cody et al. CANCER GENE THERAPY
- Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo
- (2010) Irene Zinonos et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis
- (2009) Tilman D. Rachner et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
- (2009) Penny E Reid et al. Molecular Cancer
- 17β-Estradiol inhibits osteoprotegerin production by the estrogen receptor-α-positive human breast cancer cell line MCF-7
- (2008) Tilman D. Rachner et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Role of full-length osteoprotegerin in tumor cell biology
- (2008) G. Zauli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started